| Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing M Manske, O Miotto, S Campino, S Auburn, J Almagro-Garcia, G Maslen, ... Nature 487 (7407), 375-379, 2012 | 562 | 2012 |
| Rhodococcus equi: the many facets of a pathogenic actinomycete JA Vázquez-Boland, S Giguère, A Hapeshi, I MacArthur, E Anastasi, ... Veterinary microbiology 167 (1-2), 9-33, 2013 | 137 | 2013 |
| Network medicine for disease module identification and drug repurposing with the NeDRex platform S Sadegh, J Skelton, E Anastasi, J Bernett, DB Blumenthal, G Galindez, ... Nature communications 12 (1), 6848, 2021 | 93 | 2021 |
| An Effective Method to Purify Plasmodium falciparum DNA Directly from Clinical Blood Samples for Whole Genome High-Throughput Sequencing S Auburn, S Campino, TG Clark, AA Djimde, I Zongo, R Pinches, ... PloS one 6 (7), e22213, 2011 | 91 | 2011 |
| An invertron-like linear plasmid mediates intracellular survival and virulence in bovine isolates of Rhodococcus equi A Valero-Rello, A Hapeshi, E Anastasi, S Alvarez, M Scortti, WG Meijer, ... Infection and immunity 83 (7), 2725-2737, 2015 | 86 | 2015 |
| Pangenome and Phylogenomic Analysis of the Pathogenic Actinobacterium Rhodococcus equi E Anastasi, I MacArthur, M Scortti, S Alvarez, S Giguere, ... Genome biology and evolution 8 (10), 3140-3148, 2016 | 67 | 2016 |
| Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi E Anastasi, S Giguere, LJ Berghaus, MK Hondalus, JM Willingham-Lane, ... Journal of Antimicrobial Chemotherapy 70 (12), 3184-3190, 2015 | 58 | 2015 |
| Comparative Genomics of Rhodococcus equi Virulence Plasmids Indicates Host-Driven Evolution of the vap Pathogenicity Island I MacArthur, E Anastasi, S Alvarez, M Scortti, JA Vázquez-Boland Genome Biology and Evolution 9 (5), 1241-1247, 2017 | 44 | 2017 |
| NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype MH Elbatreek, S Sadegh, E Anastasi, E Guney, C Nogales, T Kacprowski, ... PLoS Biology 18 (11), e3000885, 2020 | 42 | 2020 |
| Clonal confinement of a highly mobile resistance element driven by combination therapy in Rhodococcus equi S Álvarez-Narváez, S Giguère, E Anastasi, J Hearn, M Scortti, ... MBio 10 (5), 10.1128/mbio. 02260-19, 2019 | 30 | 2019 |
| Cancer driver drug interaction explorer M Hartung, E Anastasi, ZM Mamdouh, C Nogales, HHHW Schmidt, ... Nucleic Acids Research 50 (W1), W138-W144, 2022 | 20 | 2022 |
| Lacking mechanistic disease definitions and corresponding association data hamper progress in network medicine and beyond S Sadegh, J Skelton, E Anastasi, A Maier, K Adamowicz, A Möller, ... Nature Communications 14 (1), 1662, 2023 | 10 | 2023 |
| A Bayesian approach using covariance of single nucleotide polymorphism data to detect differences in linkage disequilibrium patterns between groups of individuals TG Clark, SG Campino, E Anastasi, S Auburn, YY Teo, K Small, ... Bioinformatics 26 (16), 1999-2003, 2010 | 4 | 2010 |
| NeDRex-an integrative and interactive network medicine platform for drug repurposing S Sadegh, J Skelton, E Anastasi, DB Blumenthal, A Maier, G Galindez, ... RExPO22, 2022 | 3 | 2022 |
| Drug repurposing prediction for COVID-19 using probabilistic networks and crowdsourced curation DJ Skelton, A Alsobhe, E Anastasi, C Atallah, JE Bird, B Brown, D Didon, ... arXiv preprint arXiv:2005.11088, 2020 | 3 | 2020 |
| Network pharmacology drug repurposing strategy for neurovascular diseases AI Casas, C Nogales, MH Elbatreek, S Sadegh, E Anastasi, J Skelton, ... RExPO22, 2022 | 1 | 2022 |
| NeDRex-Web: An Interactive Web Tool for Drug Repurposing by Exploring Heterogeneous Molecular Networks A Maier, M Rafiei, E Anastasi, O Zolotareva, J Skelton, ML Elkjaer, ... 2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2024 | | 2024 |
| Streamlining and generalizing network-based drug discovery with NeDRex and Drugst. One FM Delgado-Chaves, S Sadegh, J Skelton, A Maier, M Hartung, ... RExPO23, 2023 | | 2023 |
| Why the way we define diseases prevents innovation and precision medicine ZMMA Gomaa, E Anastasi, A Hassan, J Boltze, M Elbatreek, CN Calvo, ... | | 2023 |
| Why the way we define diseases prevents innovation and precision medicine ZM Mamdouh, E Anastasi, AA Hassan, J Boltze, MH Elbatreek, C Nogales, ... DrugRxiv, 2023 | | 2023 |